我們已在上線!
進一步了解
NMTR
9 Meters Biopharma
NMTR
NMTR
已下市
NMTR已於2023年7月25日下市。
關於: 9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003, and others.
員工: 10
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於NMTR的最新新聞文章。
價格圖表採用Lightweight Charts™實作